Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $7.61 USD
Change Today +0.03 / 0.40%
Volume 681.4K
As of 8:10 PM 08/4/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

William G. Harris

Chief Financial Officer and Senior Vice President of Finance, Xenoport, Inc.
AgeTotal Calculated CompensationThis person is connected to 9 board members in 1 different organizations across 2 different industries.

See Board Relationships
57$990,441
As of Fiscal Year 2014

Background*

Mr. William G. Harris, also known as Bill, has been the Chief Financial Officer and Senior Vice President of Finance of Xenoport, Inc. since November 2001 and serves as its Principal Accounting Officer. From July 1996 to January 2000, Mr. Harris served as the Chief Financial Officer and Vice President of Coulter Pharmaceutical. He served as Senior Vice President of Coulter Pharmaceutical since February 2000. From July 1992 to July 1996, he served as a Director of Finance ...

Read Full Background

Corporate Headquarters*

3410 Central Expressway
Santa Clara, California 95051

United States

Phone: 408-616-7200
Fax: --

Board Members Memberships*

2014-Present
Independent Director, Chairman of Audit Committee and Member of Compensation Committee

Education*

BA
University of California - San Diego
MBA
Santa Clara University Graduate School of Business

Other Affiliations*

Annual Compensation*

Salary$380,271
Total Annual Compensation$380,271

Stock Options*

Restricted Stock Awards$108,460
All Other Compensation$5,974
Exercised Options16,666
Exercised Options Value$40,498
Exercisable Options270,977
Exercisable Options Value$167,965
Unexercisable Options72,189
Unexercisable Options Value$130,600
Total Value of Options$401,202
Total Number of Options385,832

Total Compensation*

Total Annual Cash Compensation$561,170
Total Short Term Compensation$380,271
Other Long Term Compensation$114,434
Total Calculated Compensation$990,441
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
XNPT:US $7.61 USD +0.03

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Richard F. Pops Chairman of the Board and Chief Executive Officer
Alkermes plc
$854.7K
Erez Vigodman Chief Executive Officer, President, Director and Member of Finance & Invesment Committee
Teva Pharmaceutical Industries Limited
--
J. Michael Pearson Chairman and Chief Executive Officer
Valeant Pharmaceuticals International, Inc.
$1.9M
Timothy J. Miller Ph.D.Chief Executive Officer, President and Director
Abeona Therapeutics Inc.
--
Peter William Grant Chief Executive Officer and Executive Director
Skyepharma PLC
567.0K GBP
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact XENOPORT INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.